-
ABOUT USThe company is a professional API manufacturer established and developed by Shijiazhuang No.4 Pharmaceutical Group to actively promote the development strategy of "API + preparation"
-
INNOVATIONDevelops fine, series, high-end API and innovative API intermediates with high added value through overcoming key technologies such as API synthesis to build variety competition advantages.
-
PRODUCTSWith the annual production 500MT of hydroxyethyl starch , 500MT of azithromycin , we are ranking in the API professional enterprises in Hebei Province and even in China .
-
RECRUITGuolong has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities
-
CONTACTAdhering to the "love the people with quality, formed the base with integrity" business philosophy, is committed to developing the domestic high-end market and the international market.
The “Cangzhou Affection—Hometown Visit” Entrepreneurial Delegation Praises the Development of Guangxiang Pharmaceutical under Shisi Pharmaceutical Group.
Category:
Time:2021-09-22
【概要描述】
On September 19, 130 representatives from chambers of commerce and entrepreneurs from both inside and outside the province, who had attended the inaugural “Cangzhou Affection—Hometown Visit” Entrepreneurs’ Mid-Autumn Festival Gathering and Cangzhou Investment Environment Promotion Conference, visited Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisi Pharmaceutical Group in the Bohai New Area of Cangzhou for an inspection tour.
On September 19, 130 representatives from chambers of commerce and entrepreneurs from both inside and outside the province, who had attended the inaugural “Cangzhou Affection—Hometown Visit” Entrepreneurs’ Mid-Autumn Festival Gathering and Cangzhou Investment Environment Promotion Conference, visited Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisi Pharmaceutical Group in the Cangzhou Bohai New Area. Yin Weijiang, Vice Mayor of Cangzhou City, and Yu Zengzhou, Deputy Director of the Management Committee of the Cangzhou Bohai New Area, accompanied the visit.
Members of the inspection team listened with great interest to a briefing on the company’s innovation and business development at Guangxiang Pharmaceutical Co., Ltd. of Shisi Pharmaceutical Group in Bohai New Area, and expressed heartfelt admiration for the achievements Shisi Pharmaceutical Group has made in seizing the opportunities presented by the coordinated development of the Beijing-Tianjin-Hebei region and accelerating its transition toward innovative, green, and high-quality growth. The inspection team noted that Shisi Pharmaceutical Group’s persistent efforts and valuable experience in promoting enterprise transformation and upgrading are highly worthy of study and reference by businesses across the board.
Members of the inspection team unanimously expressed that the Cangzhou Bohai New Area has received high attention from both the provincial and municipal authorities. It boasts a strategic coastal location and leads the way in green development technologies. Once barren saline-alkali lands, it has now transformed into an attractive investment hub with stunning scenery. With the support of major strategic opportunities as well as national-level parks and bases, the area holds tremendous potential for future development.
Keywords:
Recommended
Share to
SERVICE HOTLINE
Zip Code: 052165
Address: No.9 Xingye Street, Gaocheng District, Shijiazhuang City, Hebei Province
Mobile site
E code
Business license